Providencia
| style="background:#Template:Taxobox colour;"|Providencia | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Providencia alcalifaciens
| ||||||||||||
| style="background:#Template:Taxobox colour;" | Scientific classification | ||||||||||||
| ||||||||||||
| Species | ||||||||||||
|
P. stuartii |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Providencia is a Gram negative, motile bacterium of the family Enterobacteriaceae. Some strains (P. stuartii, for example) are opportunistic pathogens in humans and can cause urinary tract infections, particularly in patients with long-term indwelling urinary catheters or extensive severe burns. Other strains (for example P. burhodogranariea and P. sneebia) are found in the haemolymph of Drosophila melanogaster fruit flies. Some strains are sensitive to ampicillin.
Organism
Role in diseae
Diagnosis and Testing
Gallery
-
![Providencia alcalifaciens bacteria cultured on a blood agar plate (BAP). From Public Health Image Library (PHIL). [1]](/images/e/ef/Enterobacteria42.jpeg)
Providencia alcalifaciens bacteria cultured on a blood agar plate (BAP). From Public Health Image Library (PHIL). [1]
![Providencia alcalifaciens bacteria cultured on a blood agar plate (BAP). From Public Health Image Library (PHIL). [1]](/index.php/File:Enterobacteria42.jpeg)
Antimicrobial regimen
- Providencia[2]
- 1. Complicated uti/bacteremia/acute prostatitis
- Preferred regimen (1): Ciprofloxacin 500-750 mg PO q12h or 400 mg IV q8-12h
- Preferred regimen (2): Levofloxacin 500 mg IV/PO q24h
- Preferred regimen (3): Piperacillin-Tazobactam 3.375 mg IV q6h
- Preferred regimen (4): Ceftriaxone 1-2 g IV q24h (donot use if ESBL suspected or critically ill)
- Preferred regimen (5): Meropenem 1 g IV q8h (consider if critically ill or ESBL suspected)
- Preferred regimen (6): Amikacin 7.5 mg/kg IV q12h
- Preferred regimen (7): Gentamicin
- Preferred regimen (8): Tobramycin acceptable if susceptible but many species are resistant
- Note (1): Duration of treatment for (UTI) is 7 days common or 3-5 days after defervescence or control/elimination of complicating factors (e.g.,removal of foreign material catheter).
- Note (2): Duration of treatment for (bacteremia) is 10-14 days or 3-5 days after defervescence or control/elimination of complicating factors
- Note (3): Duration for acute prostatitis (2 weeks), shorter than chronic prostatitis (4-6 weeks)
- Alternative regimen: TMP-SMX DS PO q12h for 10-14 days or TMP 5-10 mg/kg/day IV q6h
References
- Ryan KJ; Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed. ed.). McGraw Hill. ISBN 0-8385-8529-9.
- ↑ "Public Health Image Library (PHIL)".
- ↑ Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.